
Tissue metabolomics enables comprehensive characterization of metabolic processes, but its application is limited by variability introduced during sample collection, storage, homogenization, extraction, and quantification. Standardization of such factors is therefore critical to ensure reproducible and comparable datasets for intra-study data processing and inter-study data merging and comparison. This study presents an optimized and standardized workflow for robust metabolite extraction from pork muscle tissue for targeted mass spectrometry, systematically evaluating key parameters affecting metabolite yield to identify conditions that maximize yield, reproducibility and metabolite class coverage. The workflow integrates bead-based tissue homogenization with a two-step metabolite and lipid extraction protocol. Specifically, the impact of (i) tissue weight (TW) to homogenization solution (HS) volume ratios, (ii) different homogenate extract (HX) volumes and (iii) total homogenate volume (THV) on metabolite extraction performance is discussed. Based on metabolite class coverage, optimal conditions are identified. A TW-to-HS ratio of 1:12 and a HX volume of 25 µL provided better and more reproducible results. Under these standardized conditions, more than 350 metabolites were consistently quantified, spanning a wide range of chemical classes, including polar, semi-polar and non-polar species. This study highlights the importance of employing identical TW-to-HS ratios throughout a study, standardizing the description of tissue homogenization experiments by stating the TW-to-HS ratio together with their respective units and the calculated THV used. These are critical determinants for obtaining high reproducibility, accuracy and comparability in tissue metabolomics, especially in clinical areas involving tissue research.
Acacia dealbata, native to southeastern Australia, has documented traditional uses but remains underexplored as a source of bioactive metabolites. Comprehensive, bioassay-guided phytochemical characterization is needed to identify the bioactive compounds present in the plant. This study aimed to identify the bioactive phytochemicals responsible for antioxidant and antimicrobial activities of A. dealbata leaf and bark extracts using an integrated metabolomics and natural products chemistry workflow. Leaf and bark samples were extracted using solvents of varying polarity (n-heptane, ethyl acetate, methanol, water, and water: acetonitrile: isopropanol, 2:3:3). Extracts were evaluated for antioxidant and antimicrobial activities and characterised using an LC–MS/MS-based metabolomics workflow incorporating MZmine, GNPS molecular networking, SIRIUS in silico annotation, and taxonomically informed metabolite annotation (TIMA). Bioactive extracts were fractionated by preparative HPLC, followed by bioactivity-guided assessment, quantitative LC–MS analysis using standards, and NMR spectroscopy. Methanol leaf extract and ethyl acetate bark extract exhibited the strongest antioxidant and antimicrobial activities. Preparative fractionation identified flavonoids and glycosides as the dominant metabolite classes in both extracts, while terpenoids and alkaloids were also abundant in leaf fractions. Quantitative LC–MS identified rutin as the predominant compound in leaf bioactive fractions, whereas catechin, epigallocatechin, and procyanidin B2 predominated in bark fractions. NMR confirmed enrichment of flavonoid O-glycosides and simple phenolics in leaf fractions and flavan-3-ols and proanthocyanidins in bark fractions. This integrated workflow linked metabolomic profiling with bioactivity, demonstrating that A. dealbata leaves and bark are promising sources of bioactive polyphenols that can act against oxidative stress and infectious diseases.
Urinary metabolomics using liquid chromatography-mass spectrometry (LC-MS) holds great potential for biomarker discovery and clinical application. Large-scale studies and clinical trials require rapid, scalable methods. However, existing urine extraction and LC-MS approaches lack standardisation and clear recommendations for high-throughput use. To optimise a dilute-and-shoot urinary metabolite extraction and untargeted ultra-high-performance LC-MS (UHPLC-MS) method suitable for large-scale studies, and to demonstrate its performance in a clinical cohort. We systematically optimised eight parameters: extraction solvent, dilution factor, chromatographic gradient, injection volume, flow rate, gradient curve factor, full scan automatic gain control (AGC) and MS/MS AGC. Performance was assessed by the number of metabolites detected, peak quality, creatinine performance and peak quality factors (PQFs). The optimised method was applied to 1094 urine samples (862 clinical samples plus QCs) from healthy controls and patients with inflammatory bowel disease (IBD). We compared three normalisation strategies for their effect on data precision: no normalisation, creatinine normalisation and probabilistic quotient normalisation (PQN). The optimised method used a C18 column in positive ionisation mode. The mobile phases were water and acetonitrile, each with 0.1
Rabies remains a neglected zoonotic disease of global public health importance because of its near-universal fatality, limited reliable antemortem diagnostic options, and absence of effective treatment following the onset of clinical signs. However, metabolic alterations in dogs that are rabies-positive but show no observable clinical signs remain poorly characterized. Therefore, this study aimed to identify differentially abundant metabolites in apparently clinically healthy, direct fluorescent antibody (DFA)-positive dogs compared with DFA-negative dogs. Samples comprising brain tissue, serum, and cerebrospinal fluid (CSF) were collected from 231 apparently clinically healthy dogs. Rabies virus antigen was detected in brain tissue using the direct fluorescent antibody (DFA) test, and dogs were classified as rabies-positive or negative based on the results. Metabolites were extracted from serum and CSF using a validated sample preparation procedure for untargeted metabolomics. Metabolomic profiling was performed using comprehensive two-dimensional gas chromatography coupled with time-of-flight mass spectrometry (GC×GC-TOFMS) under optimized analytical conditions. Rabies virus antigen was detected in 20 of 231 brain tissue samples (8.7
High-grade cervical intraepithelial neoplasia (CIN 2–3) is a precursor lesion to cervical cancer and, although it presents different probabilities of regression and progression, it is usually grouped together in screening and managed similarly. However, the mechanisms that determine its evolution are still poorly understood, and standard treatment by conization can lead to reproductive complications such as subfertility and premature birth. This study aimed to identify metabolic and lipid signatures that can distinguish between CIN 2 and CIN 3 lesions using liquid chromatography-high-resolution mass spectrometry (LC-HRMS). Tissue samples from the lesion and adjacent margin of 24 women with CIN 2–3 were subjected to metabolomic and lipidomic analysis by LC-HRMS. Multivariate statistical analyses, pathway analysis, and correlation were performed to understand these neoplasms’ development and progression and identify potential metabolites and lipids to distinguish such lesions. Metabolomic and lipidomic analysis by LC-HRMS in cervical tissue identified molecular signatures with differential abundance between CIN 2 and CIN 3, highlighting patterns associated with the degree of lesion. Multivariate analyses highlighted metabolites (serine, glutamic acid, guanidine-6-monophosphate, succinic acid, mannose 6-phosphate, and taurine) and lipids (TG 49:1, TG 50:1, and TG 52:2) as the main contributors to the discrimination between the groups, suggesting relevant biological alterations in high-grade cervical lesions. Combination metabolomic and lipidomic approach enabled the identification of metabolites and lipids potentially involved in the pathogenesis of intraepithelial neoplasia (CINs). In addition, these identified metabolite and lipid panels are promising as complementary tools for future screening strategies for these lesions.